Hemostatic Disorders

Hemostatic Disorders is a topic covered in the Washington Manual of Medical Therapeutics.

To view the entire topic, please log in or purchase a subscription.

The Washington Manual of Medical Therapeutics helps you diagnose and treat hundreds of medical conditions. Consult clinical recommendations from a resource that has been trusted on the wards for 50+ years. Explore these free sample topics:

Washington Manual

Aortic RegurgitationAortic Regurgitation

DyslipidemiaDyslipidemia

Mitral StenosisMitral Stenosis

SeizuresSeizures

-- The first section of this topic is shown below --

General Principles

Normal hemostasis involves a sequence of interrelated reactions that lead to platelet aggregation (primary hemostasis) and activation of coagulation factors (secondary hemostasis) to produce a durable vascular seal.

  • Primary hemostasis consists of an immediate but temporary response to vessel injury, where platelets and von Willebrand factor (vWF) interact to form a primary hemostatic plug.
  • Secondary hemostasis results in formation of a fibrin clot (Figure 20-1). Injury exposes extravascular tissue factor to blood, which initiates activation of factors VII and X and prothrombin. Subsequent activation of factors XI, VIII, and V leads to generation of thrombin, conversion of fibrinogen to fibrin, and formation of a durable clot.1
    Figure 20-1 Coagulation cascade.

    Solid arrows indicate activation. Solid or dashed lines that run into a vertical line are associated with drugs represent a point of inhibition. Extrinsic pathway includes the right upper portion of cascade above factor X. Intrinsic pathway includes the left upper portion of the cascade above factor X. Common pathway includes the lower portion of the cascade from factor X and below. AT, antithrombin; LMWH, low-molecular-weight heparin; TF, tissue factor.

-- To view the remaining sections of this topic, please log in or purchase a subscription --

General Principles

Normal hemostasis involves a sequence of interrelated reactions that lead to platelet aggregation (primary hemostasis) and activation of coagulation factors (secondary hemostasis) to produce a durable vascular seal.

  • Primary hemostasis consists of an immediate but temporary response to vessel injury, where platelets and von Willebrand factor (vWF) interact to form a primary hemostatic plug.
  • Secondary hemostasis results in formation of a fibrin clot (Figure 20-1). Injury exposes extravascular tissue factor to blood, which initiates activation of factors VII and X and prothrombin. Subsequent activation of factors XI, VIII, and V leads to generation of thrombin, conversion of fibrinogen to fibrin, and formation of a durable clot.1
    Figure 20-1 Coagulation cascade.

    Solid arrows indicate activation. Solid or dashed lines that run into a vertical line are associated with drugs represent a point of inhibition. Extrinsic pathway includes the right upper portion of cascade above factor X. Intrinsic pathway includes the left upper portion of the cascade above factor X. Common pathway includes the lower portion of the cascade from factor X and below. AT, antithrombin; LMWH, low-molecular-weight heparin; TF, tissue factor.

There's more to see -- the rest of this entry is available only to subscribers.